NFKB1 and lung carcinoma: Some of the NF-κB inhibitors that enhanced lung cancer cell death induced by chemotherapeutics are genistein with cisplatin or docetaxel [53,54], embelin with paclitaxel [55], expression of IκBα mutant with cisplatin, gemcitabline, adriamicin and etoposide [56,57].